Robust in vitro HBV infection systemsregist2.virology-education.com/presentations/2017/... · 2017....

19
Robust in vitro HBV infection systems Lefteris Michailidis, Ph.D. Laboratory of Virology and Infectious Disease Charles M. Rice Laboratory The Rockefeller University December 4, 2017

Transcript of Robust in vitro HBV infection systemsregist2.virology-education.com/presentations/2017/... · 2017....

  • Robust in vitro HBV infection systems

    Lefteris Michailidis, Ph.D.

    Laboratory of Virology and Infectious DiseaseCharles M. Rice LaboratoryThe Rockefeller University

    December 4, 2017

  • NTCP discovery

    Overexpression of NTCP in hepatoma cells De novo HBV infection

    NTC

    PDA

    PI

    HepG2-NTCP (clone 7)

    Yan et al. eLife (2012)Ni et al., Gastroenterology (2014)Michailidis et al. Sci Rep (2017)

  • HBV infection of HepG2-NTCP cells

    Michailidis et al. Sci Rep (2017)

  • Need for more robust systems

    High titers for infectionNo virus spread

    X

  • HepG2-NTCP produce infectious HBV

    …but there is no spread Michailidis et al. Sci Rep (2017)

  • Continuous addition of PEG results in HBV spread

    Michailidis et al. Sci Rep (2017)

  • Complete HBV life cycle

  • HCV, YFV, WNV, VEEV, HIV-1, AdV, Flu…

    Schoggins et al., Nature (2011)

    Schoggins et al., Nature (2014)

    Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity

    A serpin shapes the extracellular environment to prevent influenza A virus maturation

    Dittmann et al., Cell (2015)

    ISG screens in the Rice lab

    A diverse range of gene products are effectors of the type I interferon antiviral response.

  • Anti-HBV ISG screens

    Transduce with lenti-ISG library

    Day -2 0 1

    Wash/±PEG

    7 13

    Fix Fix

    CMV ISG EMCVIRES RFP

  • HBV+MyrB HBV

    Anti-HBV ISG screens

    DAPIDAPI

    RFP

    HBcAg

    Total number of cells

    Transduced cells

    HBcAg positive cells

    Non-transduced Transduced

  • + PEG

  • + PEG

  • + PEG

  • ISG20

    Yan et al., JVI (2015)Lv et al., Sci Rep (2015)Leong et al., Oncotarget (2016)Liu et al. PloS Pathogens (2017)Michailidis et al. Sci Rep (2017)

    Control

    Tetherin

  • Continuous PEG treatment facilitates HBV spread in HepG2-NTCP cells

    HBV spread system can be efficiently applied in antiviral screens

    Summary

  • Acknowledgments The Rockefeller UniversityCharles M. RiceYpe de JongJonathan PabonPaul ParkWilliam SchneiderHeinrich HoffmannAlison AshbrookXianfang WuRice lab

    AlumniAmir ShlomaiTel Aviv University

    Kuanhui Xiang Beijing University

    CollaboratorsAmir ShlomaiTel Aviv University

    Sangeeta N. BhatiaVyas RamananMIT

    ReagentsHaitao GuoIndiana University

    Stephan UrbanHeidelberg University

    Robertson Therapeutic Development Fund

    Dianummer 1Dianummer 2Dianummer 3Dianummer 4Dianummer 5Dianummer 6Dianummer 7Dianummer 8Dianummer 9Dianummer 10Dianummer 11Dianummer 12Dianummer 13Dianummer 14Dianummer 15Dianummer 16Dianummer 17Dianummer 18Dianummer 19